OpenVSafe by OpenVAERS
Search V-safe

4VG-33684-07694

2 vaccinations 6 coded responses 8 check-ins 6 free-text entries 1 call case
Sex
Female
Age at first dose
61-65
ZIP prefix
104 / NY
Registered
2021-07-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-07-07
    Dose 1 — Pfizer-BioNTech
  2. 2021-07-22
    Registered in v-safe
  3. 2021-07-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-08-06
    Dose 2 — Pfizer-BioNTech
  5. 2021-08-18
    Survey response — day 7, dose 2
    MedDRA: Fatigue, Lymph node pain — Feeling: Good · Site: Itching · Fatigue or tiredness
    Free text: I felt achy in my neck glands. A bit tired.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  6. 2021-08-20
    Survey response — day 14, dose 2
    MedDRA: Fatigue, Gastrointestinal disorder, Headache, Musculoskeletal chest pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Pain near/under ribs & some intestinal issues. Almost daily headaches. Very tired.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  7. 2021-08-27
    Survey response — day 21, dose 2
    MedDRA: Fatigue, Initial insomnia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Mostly just exhaustion and difficulty falling asleep.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  8. 2021-09-05
    Survey response — day 28, dose 2
    MedDRA: Asthenia, Gastrointestinal disorder, Tachycardia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Tachycardia & weakness. Also a change in my digestive system.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  9. 2021-09-05
    Report sent to call center — day 28, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  10. 2021-09-10
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-09-15
    Call successful
    Participant prefers to complete VAERS report online
  12. 2021-09-17
    Survey response — day 42, dose 2
    MedDRA: Body temperature increased, Diarrhoea, Fatigue, Gastrointestinal disorder, Gastrointestinal pain, Headache, Heart rate increased — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Elevated temperature, headaches, digestive issues (cramps & diarrhea), fast heartbeat, tiredness/general fatigue.
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-02-04
    Survey response — 6 months, dose 2
    MedDRA: Asthenia, Dyspnoea, Gastrointestinal disorder, Muscular weakness — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Digestive difficulties & some heart palpitations & breathlessness & some periodic weakness.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-07-07Pfizer-BioNTech No
22021-08-06Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 9 — day 7, dose 2

2021-08-18

Systemic reaction (other): I felt achy in my neck glands. A bit tired.

Release 9 — day 14, dose 2

2021-08-20

Symptoms: Pain near/under ribs & some intestinal issues. Almost daily headaches. Very tired.

Release 9 — day 21, dose 2

2021-08-27

Symptoms: Mostly just exhaustion and difficulty falling asleep.

Release 9 — day 28, dose 2

2021-09-05

Symptoms: Tachycardia & weakness. Also a change in my digestive system.

Release 9 — day 42, dose 2

2021-09-17

Symptoms: Elevated temperature, headaches, digestive issues (cramps & diarrhea), fast heartbeat, tiredness/general fatigue.

Release 11 — 6 months, dose 2

2022-02-04

Symptoms: Digestive difficulties & some heart palpitations & breathlessness & some periodic weakness.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAsthenia ✓ · ✓
SDBody temperature increased · · ✓
SDDiarrhoea · · ✓
SDDyspnoea · · ✓
SDFatigue ✓ · ✓
SDGastrointestinal disorder ✓ · ✓
SDGastrointestinal pain · · ✓
SDHeadache ✓ · ✓
SDHeart rate increased · · ✓
SDInitial insomnia ✓ · ✓
SDMuscular weakness · · ✓
SDMusculoskeletal chest pain ✓ · ✓
SDTachycardia ✓ · ✓
SROFatigue ✓ · ✓
SROLymph node pain ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release